Impax Investor Says Drug Price-Fixing Probe Never Disclosed
Impax Laboratories Inc. was smacked Thursday with a shareholder suit in New Jersey federal court accusing the bioequivalent and generic drugmaker of failing to disclose to investors a U.S. Department of...To view the full article, register now.
Already a subscriber? Click here to view full article